Replies to post #266505 on NorthWest Biotherapeutics Inc (NWBO)

[sukus]

Agreed with shortening future trials Doc. Is that in line with FDA initiatives recently? Looks like it but I am not 100% sure. Hope that NWBO included in the SAP about surrogate biomarker and hopefully the regulators can see how scientific and how precise these findings are presented for them to review.